The American Roswell Park Cancer Institute (RPCI) wants to acquire the Cuban vaccine developed by the Center of Molecular Immunology (CIM), in Havana, CimaVax, a therapeutic vaccine, attacking proteins that allow a tumor to continue to grow, prevents proliferation by the body and helps to prolong life in patients.
Read More